Procaps Group (NASDAQ:PROC) Trading Down 3%

Shares of Procaps Group S.A. (NASDAQ:PROC) dropped 3% during trading on Thursday . The stock traded as low as $2.59 and last traded at $2.60. Approximately 9,167 shares changed hands during trading, a decline of 57% from the average daily volume of 21,215 shares. The stock had previously closed at $2.68.

Procaps Group Stock Down 3.0 %

The company has a debt-to-equity ratio of 5.74, a current ratio of 1.47 and a quick ratio of 0.99. The firm’s 50-day moving average is $3.06 and its 200 day moving average is $3.21. The stock has a market cap of $293.33 million, a price-to-earnings ratio of 5.00 and a beta of 0.13.

Hedge Funds Weigh In On Procaps Group

Several institutional investors and hedge funds have recently bought and sold shares of PROC. Millennium Management LLC increased its position in shares of Procaps Group by 15.9% in the second quarter. Millennium Management LLC now owns 101,430 shares of the company’s stock worth $945,000 after acquiring an additional 13,908 shares in the last quarter. Exome Asset Management LLC bought a new position in Procaps Group during the 4th quarter valued at $516,000. Citadel Advisors LLC bought a new position in Procaps Group during the 2nd quarter valued at $263,000. Geode Capital Management LLC boosted its stake in Procaps Group by 13.7% during the 1st quarter. Geode Capital Management LLC now owns 21,223 shares of the company’s stock valued at $96,000 after acquiring an additional 2,562 shares during the last quarter. Finally, State Street Corp bought a new position in Procaps Group during the 3rd quarter valued at $89,000.

Procaps Group Company Profile

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.